New Genomic Analysis Platform

Applied Biosystems has announced that it is to begin shipment of a new genomic analysis platform, the SOLiD 3 System. The new system delivers a roadmap that will ultimately enable scientists to sequence a human genome for less than 10,000 US dollars in 2009.

This advanced genomics system enables life science researchers to sequence entire genomes of all organisms at a much lower cost.

It also expands the menu of applications into gene  expression and epigenetic analysis, ultimately allowing  customers to move one step closer to mainstream use of genomic data for clinical research and personalised medicine.

The SOLiD 3 System, which is distinguished by unparalleled throughput and unmatched accuracy, has generated 40 gigabases of data per sequencing run in Applied Biosystems’ research and development laboratories, with an accuracy of 99.94 % due to 2-base encoding algorithms.

The combination of these performance attributes further establishes Applied Biosystems’ next-generation sequencing approach as the technology platform of choice for a broad range of advanced genomics research.